Related Experiment Video
Updated: Jun 12, 2026
06:24
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Pharmacokinetic mapping for lesion classification in dynamic breast MRI
Matthias C Schabel1, Glen R Morrell, Karen Y Oh
1University of Utah Department of Radiology, Salt Lake City, Utah 84132, USA. matthias.schabel@hsc.utah.edu
Journal of Magnetic Resonance Imaging : JMRI
|June 1, 2010
Summary
Dynamic MRI with pharmacokinetic modeling accurately distinguishes benign breast lesions from malignancies. This rapid MRI approach offers high sensitivity and specificity, aiding in cancer diagnosis.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Distinguishing benign from malignant breast lesions is crucial for effective patient management.
- Dynamic MRI is a valuable tool, but its diagnostic accuracy can be enhanced.
Purpose of the Study:
- To evaluate a rapid dynamic MRI protocol combined with pharmacokinetic modeling for differentiating benign from malignant breast lesions.
- To assess the diagnostic utility of pharmacokinetic parameters in breast lesion classification.
Main Methods:
- A prospective study involving patients referred for breast biopsy.
- Dynamic MRI scans with complete bilateral breast coverage were performed.
- Pharmacokinetic parameters (K(trans), k(ep), v(p), v(e)) were calculated and used to generate receiver operating characteristic curves for classification.
Main Results:
- Analysis of 93 lesions revealed high accuracy using K(trans) and k(ep).
- The two-parameter classifier achieved an area under the curve of 0.915, with 91% sensitivity and 85% specificity.
- These results surpass those of recent clinical breast MRI studies in specificity.
Conclusions:
- Pharmacokinetic classification using rapid dynamic MRI is practical and accurate for identifying malignant breast lesions.
- This method offers improved specificity compared to traditional clinical breast MRI.
- The findings support the use of dynamic MRI with pharmacokinetic modeling in breast lesion diagnosis.
